Chemosense Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Chemosense Therapeutics General Information

Description

Developer of novel cancer therapeutics designed to sensitize tumors to existing chemotherapeutic agents and overcome chemotherapy resistance. The company's therapeutics target and block receptors that maintain chemoresistance, enabling healthcare providers to restore sensitivity in resistant tumors, prolong chemotherapy effectiveness, and minimize adverse side effects through reduced dosages.

Contact Information

Website
www.chemosensetherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 2315 Cambridge Court
  • Moscow, ID 83843
  • United States
+1 (515)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 2315 Cambridge Court
  • Moscow, ID 83843
  • United States
+1 (515)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chemosense Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 26-Oct-2026 Completed Out of Business
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 16-Jan-2020 Completed Startup
To view Chemosense Therapeutics’s complete valuation and funding history, request access »

Chemosense Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Washington State University University
To view Chemosense Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Chemosense Therapeutics FAQs

  • When was Chemosense Therapeutics founded?

    Chemosense Therapeutics was founded in 2020.

  • Where is Chemosense Therapeutics headquartered?

    Chemosense Therapeutics is headquartered in Moscow, ID.

  • What industry is Chemosense Therapeutics in?

    Chemosense Therapeutics’s primary industry is Drug Discovery.

  • Is Chemosense Therapeutics a private or public company?

    Chemosense Therapeutics is a Private company.

  • What is Chemosense Therapeutics’s current revenue?

    The current revenue for Chemosense Therapeutics is .

  • Who are Chemosense Therapeutics’s investors?

    Washington State University has invested in Chemosense Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process